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Aim. Delayed bleeding after endoscopic submucosal dissection (ESD) for gastric epithelial neoplasms is a major complication. We
investigatedfactorsrelatedtopost-ESDbleedingtoidentifypreventivemeasures.Methods.Thestudyincluded161gastricepithelial
neoplasmsin142patientsfromJune2007toSeptember2010.Post-ESDbleedingwasdeﬁnedasanulcerwithactivebleedingorap-
parentexposedvesselsdiagnosedbyanemergencyendoscopyoraplannedfollow-upendoscopy.Weanalyzedassociationsbetween
bleeding and the following factors: age, sex, morphology, pathology, tumor depth, ulcer presence/absence, location, size of the re-
sected lesion, duration of the procedure, the number of times bleeding occurred during ESD, and the use of anticoagulants and/or
antiplatelet drugs. Subsequently, we examined characteristics of bleeding cases. Results. Post-ESD bleeding occurred in 21 lesions.
Univariate analysis of these cases showed that ulcer presence/absence (P<0.001), middle or lower third lesions (P = 0.036), cir-
cumference (P = 0.014), and a post-ESD ulcer with an extended lesser curve (P = 0.009) were signiﬁcant predictors of bleeding.
Multivariate analysis showed that ulcer presence/absence (OR 9.73, 95% CI 2.28–41.53) was the only signiﬁcant predictor. Con-
clusion. Ulcer presence/absence was considered the most signiﬁcant predictor of post-ESD bleeding.
1.Introduction
Endoscopic submucosal dissection (ESD) for gastric adeno-
masandearly gastriccancersenablesen-block resectioneven
for large or ulcerative lesions [1, 2]. However, ESD is techni-
cally demanding and is a lengthy procedure. Furthermore,
ESD can cause additional complications such as perforation
and bleeding compared with endoscopic mucosal resection
(EMR) [1–3]. Recently, ESD has been widely performed in
general hospitals, and the indications for ESD have been ex-
panded according to new criteria [4]. Accordingly, measures
to address major complications such as perforation and
bleeding have become increasingly important. Although the
frequency of complications has been decreasing with im-
provementsintechniqueandinstrumentationforESD,post-
ESD bleeding occurs in approximately 5% of cases [3, 5–7].
When post-ESD bleeding occurs, patients may suﬀer from
hematemesis, hemorrhagic shock, and other complications,
which may require emergency endoscopy and prolonged
fasting. Medical staﬀ are also impacted by the need to
perform emergency treatment. Several previous studies have
reported investigations of risk factors for post-ESD bleeding
[6, 8–12]. However, there is currently no consensus with
respect to these risk factors. Therefore, we investigated fac-
tors related to post-ESD bleeding in our patients to identify
preventive measures.
2.MaterialsandMethods
2.1. Subjects. A total of 161 gastric epithelial neoplasms in
142 patients (125 early gastric cancers and 36 gastric ade-
nomas) were consecutively treated with ESD in our hospital
from June 2007 to September 2010. ESD was determined to
be indicated for gastric epithelial neoplasms according to the
criteria of extended indication of ESD for gastric cancer in
theinstitute.Thecriteriaarethefollowing:(i)anytumorsize
if it was a diﬀerentiated adenocarcinoma (intestinal type)
without ulceration or submucosal invasion, (ii) tumor size
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suspected and it was a diﬀerentiated adenocarcinoma with-
out submucosal invasion, (iii) tumor size equal to or less
than 2cm if tumor was a undiﬀerentiated adenocarcinoma
(diﬀusetype)withoutulcerationorsubmucosalinvasion.All
patients provided informed consent before undergoing the
procedures, and patient anonymity was preserved through-
out the study. Furthermore, because this was a retrospective
study with patient anonymity, we have not taken study
approval from our institutional review board.
2.2. ESD Procedures. ESDs were performed according to
a standard protocol [1, 2]. An operator and an assistant
performed the procedure using a video endoscope (GIF-
Q260J; Olympus, Tokyo, Japan) and various instruments
for ESD. The operators included two experts (with an
experienceofmorethan50cases)andtwobeginners.Whena
beginner performed the procedure as an operator, an expert
provided complete support as an assistant and replaced the
operator as needed. After marking the lesion margins using
an APC probe (VIO 300D; Erbe, Tubingen, Germany), a
submucosal injection was performed to lift the lesion. A
mixture of 10% glycerin and hyaluronic acid containing
0.5% indigocarmine and 0.1% epinephrine was used as the
injection ﬂuid. A circumferential incision was performed
using an instrument such as needle knife, insulated-tip
knife (KD-610L, 611L; Olympus, Tokyo, Japan), or ﬂush
knife (DK2618JN20; Fujinon, Tokyo, Japan), according to
theoperator’spreference.Continuoussubmucosaldissection
of the lesion was performed. Hemostatic forceps (FD-
410LR; Olympus) were used to control bleeding during
the procedure. When ESD was completed, coagulation of
visible vessels in the resection area was also performed using
hemostatic forceps to prevent delayed bleeding. A proton
pump inhibitor (PPI), 20mg omeprazole, was administered
intravenously twice daily from the day of ESD to the day
before beginning a soft diet. Oral administration of PPIs,
20mg rabeprazole was continued from the day on which
meals were begun for approximately 2 months. A second-
look endoscopy was routinely performed the next day or
a few days after ESD before beginning meals, and a third-
look endoscopy was generally performed 8 days after ESD
before discharge, primarily to prevent delayed bleeding.
If bleeding or visible vessels that had the potential for
bleeding were detected on the ulcer, preventive treatment
was performed using hemostatic forceps or clipping with
hemostatic clips (HX-610-135; Olympus). If bleeding with
hematemesis or melena occurred, emergency endoscopic
hemostasis using hemostatic forceps, clipping, injection of
hypertonic saline epinephrine (HSE), and other necessary
treatments were performed. Generally, if adverse events,
bleeding, perforation, pneumonia, or other complications
did not occur, patients were discharged within 10 days after
ESD. A follow-up endoscopy was performed 2 months after
ESDtoconﬁrmhealingoftheulcerandtodetectnewlesions.
2.3. Data Analysis. Post-ESD bleeding was deﬁned as active
bleeding from a post-ESD ulcer diagnosed by an emergency
endoscopy or a planned follow-up endoscopy (Figure 1). In
Figure 1: Endoscopic appearance of post-ESD ulcer with active
bleeding.
Figure 2: Endoscopic appearance of post-ESD ulcer with apparent
exposed vessels.
addition, we deﬁned occult bleeding cases with a high risk of
bleeding as post-ESD bleeding. They were cases with a post-
ESD ulcer with active bleeding after washing with water or
a water jet (Olympus) or apparent exposed vessels when a
planned follow-up endoscopy was carried out (Figure 2).
To investigate factors inﬂuencing post-ESD bleeding, we
analyzedthefollowingfactorsandcomparedthegroupswith
post-ESD bleeding to the control group: age, sex, morphol-
ogy (0–I, IIa, IIc, IIa + IIc, or III), pathology (intestinal type,
diﬀuse type, or adenoma), tumor depth (mucosal tumor
or submucosal tumor), ulcer ﬁndings (endoscopically or
pathologically present or absent), tumor location in terms
of the major axis (upper third (U), middle third (M), or
lower third (L)), the circumference (anterior wall, posterior
wall, lesser curve, or greater curve), size of the resected
lesion (maximum diameter, mm), duration of the procedure
(min), the number of times bleeding occurred during ESD
(representedbythenumberoftimeshemostaticforcepswere
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were used. Subsequently, we classiﬁed the post-ESD ulcers
into two groups, ulcers with an extended lesser curve and
those without. We carried out the data analysis for cases with
post-ESD bleeding versus the control cases.
Subsequently, we analyzed several characteristics of the
cases with post-ESD bleeding, including the timing, region,
and nature of the bleeding. Timing was classiﬁed into early
phase (up to 2 days after ESD) and delayed phase (3 or
more days after ESD). The region was classiﬁed in terms of
the major axis (upper third, middle third, or lower third),
the circumference (anterior wall, posterior wall, lesser curve,
or greater curve), and location at the ulcer (ulcer margin
or ulcer center). The ulcer margin was deﬁned as bleeding
vessels in the area adjacent to the ulcer edge. The ulcer
center was deﬁned as the ulcer ﬂoor area other than the
ulcer margin. The nature of the bleeding was classiﬁed into
four types (spouting, gushing, exposed vessels, or oozing).
Furthermore, we analyzed the following symptoms and
treatments for the cases: hematemesis, anemia (decline in
Hb > 2g/dL), hemorrhagic shock (systolic blood pressure <
90mmHg), and blood transfusion.
2.4. Statistical Analysis. Univariate and multivariate analyses
were performed. Diﬀerences in the means of continuous
data, such as age, size of the resected lesion, duration of the
procedure, and the number of episodes of bleeding, were
compared using Student’s t-test for a normally distributed
population; otherwise, Mann-Whitney U test was used.
Categorical data, such as sex, morphology, pathology, tumor
depth, ulcer presence/absence, tumor location, and whether
anticoagulants and/or antiplatelet drugs were used, were
compared using a χ2 test and Fisher’s exact test. Variables
with a P value < 0.2 in the univariate analysis were included
in a forward, stepwise multiple logistic regression model.
P values < 0.05 were considered statistically signiﬁcant and
all tests were two sided. The analyses were performed using
Ekuseru-Toukei 2010 (Social Survey Research Information
Co. Ltd., Tokyo, Japan).
3. Results
Baseline data for the clinical characteristics of the 161 gastric
lesions in 142 patients are displayed in Table 1. Post-ESD
bleeding occurred in 21 (13.0%) of the 161 lesions, 9 active
bleeding, and 12 occult bleeding cases. Perforation occurred
in2patientsinESD,theyweretreatedbyendoscopicclipping
and did not required surgical treatments.
Univariate analysis showed no signiﬁcant diﬀerences
between the 21 bleeding cases and the control cases in age,
sex,morphology,pathology,tumordepth,sizeoftheresected
lesion, duration of the procedure, the number of episodes
of bleeding, or the use of anticoagulants and/or antiplatelet
drugs. Ulcer presence/absence (P<0.001), location (upper
versus middle or lower, P = 0.036), circumference (P =
0.014), and a post-ESD ulcer with an extended lesser curve
(P = 0.009) were signiﬁcantly diﬀerent between the bleeding
a n dc o n t r o lg r o u p sa n dw e r ec o n s i d e r e dp r e d i c t o r sf o rp o s t -
ESDbleeding(Table 2).Thesubsequentmultivariateanalysis
showed that ulcer presence/absence (OR 9.73, 95% CI 2.28–
41.53) was the only statistically signiﬁcant predictor of post-
ESD bleeding (Table 3).
Wetheninvestigatedthe21caseswithpost-ESDbleeding
in detail. With respect to the timing of bleeding, 15 cases
occurred in the early phase and 6 in the delayed phase.
Although the majority of the cases occurred relatively early
(within 2 days), some cases occurred about a week after ESD
(3 cases at 8 days). Bleeding at the ulcer occurred at the ulcer
margin in 9 cases and in the center of the ulcer in 12 cases.
Bleedingﬁndings,including2spouting,8gushing,5exposed
vessels, and 6 oozings were observed. 6 cases had hemateme-
sis, 4 had anemia, 4 had hemorrhagic shock, and a blood
transfusion was performed in 2 cases (Table 4). All the cases
of post-ESD bleeding were treated using endoscopic proce-
dures and did not require surgical intervention.
4. Discussion
In the present study, the presence of ulcers was the only
predictor for post-ESD bleeding with a signiﬁcant diﬀerence.
Location (middle- or lower-third region) and a post-ESD
ulcer with an extended lesser curve were also considered
predictors for post-ESD bleeding.
Post-ESD bleeding is a major complication of ESD along
with perforation, and several previous studies have reported
investigations of risk factors for post-ESD bleeding [6–12].
Previous studies have reported that the size of the
resected tumor was the only signiﬁcant risk factor for post-
ESD bleeding [8, 9]. In our study, although the univariate
analysis showed no signiﬁcant diﬀerence between the post-
ESD bleeding cases and the control cases in the size of the
resected tumor, there was a tendency toward larger size in
the bleeding cases. If a larger number of cases had been
investigated, the size of the resected tumor might have been
a signiﬁcant predictor of post-ESD bleeding.
A previous study reported that pathology was a signif-
icant risk factor for post-ESD bleeding [10]. In our study,
the analysis showed no signiﬁcant diﬀerences related to
pathology.
There is currently no consensus in the literature with
respect to the eﬀect of the location of the major axis (upper,
middle, and lower). Several previous studies have not report-
ed any signiﬁcant ﬁndings for lesion location and post-ESD
bleeding [8–10]. However, one study reported that post-ESD
bleeding was signiﬁcantly less frequent in lower region [11].
In contrast, several other studies have reported that predict-
ors of post-ESD bleeding included middle or lower region
[6]o rl o w e rr e g i o n[ 12]. Similarly, in our study, univariate
analysis of 21 bleeding cases showed that there was a signiﬁ-
cantlyhigherfrequencyofbleedinginmiddleorlowerregion
than in upper region (P = 0.036). We suggest that the higher
frequency of post-ESD bleeding in middle and lower regions
may be due to more active peristalsis in that region, as also
suggested by Takizawa et al. [6]. They further suggested that
the diameter of the submucosal arteries was larger in the
upper region than in the other regions; therefore, intra-
operative bleeding occurs more frequently and complete4 Gastroenterology Research and Practice
Table 1: Baseline characteristics of patients and gastric lesions.
Characteristic Patients and gastric lesions (n = 161)
Age (yr, mean ± SD) 72.4 ±8.8
Sex (male/female) 116/45
Anticoagulants/platelets (used/not used) 33/128
Morphology (I/IIa/IIc, IIa + IIc, III) 6/97/58
Histological type (intestinal/diﬀuse/adenoma) 121/4/36
Depth (M/SM,MP) 145/16
Ulcer ﬁndings (presence/absence) 21/140
Location (U/M/L) 22/74/65
Location (U/ML) 22/139
Circumference (AW/GC/LC/PW) 20/45/67/29
Size of resected lesion (mm, mean ± SD) 35.5 ±11.8
Procedure duration (min, mean ± SD) 81.4 ±49.4
Number of times hemostatic forceps used (mean ± SD) 4.4 ±4.8
Post-ESD ulcer (extended LC/not extended LC) 89/72
SD: standard deviation; M: mucosa; SM: submucosa; U: upper third; M: middle third: L, lower third; AW: anterior wall; GC: greater curve; LC: lesser curve;
PW: posterior wall; ESD: endoscopic submucosal dissection.
Table 2: Univariate analysis of delayed bleeding.
Factor Present (n = 21) Absent (n = 140) P value
Age (yr, mean ± SD) 70.2 ±11.67 2 .8 ±8.3 0.432
Sex (male/female) 15/6 101/39 0.847
Morphology (I/IIa/IIc, IIa + IIc, III) 1/8/12 5/89/46 0.081
Histological type (intestinal/diﬀuse/adenoma) 18/1/2 103/3/34 0.267
Depth (M/SM,MP) 21/0 124/16 0.095
Ulcer ﬁndings (presence/absence) 9/12 12/128 <0.001∗
Location (U/M/L) 0/10/11 22/64/54 0.124
Location (U/ML) 0/21 22/118 0.036∗
Circumference (AW/GC/LC/PW) 6/1/11/3 14/44/56/26 0.014∗
Size of resected lesion (mm, mean ± SD) 38.9 ±10.83 5 .0 ±11.90 . 1 7
Procedure duration (min, mean ± SD) 88.2 ±33.68 0 .4 ±51.9 0.164
Number of times hemostatic forceps used (mean ± SD) 5.6 ±3.94 .3 ±4.9 0.162
Anticoagulants/platelets (used/not used) 4/17 29/111 0.562
Post-ESD ulcer (extended LC/not extended LC) 17/4 72/68 0.009∗
SD: standard deviation; M: mucosa; SM: submucosa; U: upper third; M: middle third; L: lower third; AW: anterior wall; GC: greater curve; LC: lesser curve;
PW: posterior wall; ESD: endoscopic submucosal dissection.
∗Signiﬁcantly diﬀerent.
Table 3: Multivariate analysis of delayed bleeding.
Factors OR 95% CI P value
Morphology I 1.24 0.11–13.81 0.86
IIa 0.60 0.18–2.03 0.41
Depth (M/SM,MP) M 0.24 0.05–1.22 0.09
Ulcer ﬁndings Present 9.73 2.28–41.53 0.002∗
Location ML 1.46 0.26–8.26 0.67
Circumference
AW 1.13 0.23–5.48 0.88
LC 0.34 0.08–1.47 0.15
GC 0.11 0.01–1.27 0.08
Size of resected lesion 0.10 0.94–1.05 0.87
Procedure duration 0.99 0.97–1.01 0.17
Post-ESD ulcer Extended LC 3.23 0.68–15.42 0.14
AW: anterior wall; GC: greater curve; LC: lesser curve; PW: posterior wall; OR: odds ratio; CI: conﬁdence interval.
∗Signiﬁcantly diﬀerent.Gastroenterology Research and Practice 5
Table 4: Analysis of the 21 bleeding cases.
Timing
(0–2 days after ESD/≥3 days after ESD) 15/6
Bleeding region
Major axis (U/M/L) 0/10/11
Circumference (AW/GC/LC/PW) 4/0/15/2
At the ulcer (center/margin) 12/9
Nature of the bleeding
(Spouting/gushing/exposed vessels/oozing) 2/8/5/6
Clinical ﬁndings
(Hematemesis/anemia/shock/transfusion) 6/4/4/2
hemostasis is achieved. In contrast, there is a lower frequency
of intraoperative bleeding in the middle and lower regions,
so that vessels in these regions are not suﬃciently coagulated
and delayed bleeding may occur. Furthermore, more bile
juicereﬂuxinthelowerregionmaycontributetohigherfreq-
uency of post-ESD bleeding [6]. We agree with this reason-
ing.
In our study, we recorded and investigated the circum-
ference (anterior wall, posterior wall, lesser curve, or greater
curve) in addition to the major axis of the ulcer. Univariate
analysis of the 21 bleeding cases showed that bleeding was
signiﬁcantlymorefrequentinpost-ESDulcerswithextended
lesser curves (P = 0.009). This may be due to the many
relatively thick arteries branching from the left gastric artery
and the many arteries branching from the right gastric artery
forming an arcade with the left gastric artery in a lesser curve
[13, 14].
In the present study, the presence of ulcers was the pri-
mary predictor of post-ESD bleeding having a signiﬁcant
diﬀerence between groups in the multivariate analysis (P<
0.005). We suggest that the high frequency of post-ESD
bleeding in lesions with ulcers is due to the rich blood vessels
in ulcerative regions that grow as part of the healing pro-
cess of an ulcer [15]. Similarly, vascularization in gastric car-
cinomas may contribute to rich blood vessels in ulcerative
regions. No prior studies have identiﬁed this factor as a pre-
dictor for post-ESD bleeding. Although the reason for the
discrepancy between the previous studies and the present
study are unclear, the majority of previous studies had a ten-
dency toward high frequency of post-ESD bleeding in lesions
with ulcers [6–8, 10–12] .S e v e r a lp r e v i o u ss t u d i e sh a v er e -
ported risk factors for post-ESD bleeding, the results of these
studies, including the present study, are diverse, and there is
currently no consensus with respect to risk factors. Although
the reason for the discrepancy could not be determined, it
may include the single-center retrospective study design of
each previous studies and various uncertain factors associ-
ated with each institution, such as ESD procedures and oper-
ators. The lack of consistent results requires further consid-
eration, and meta-analysis of these studies may be useful.
Several measures to control post-ESD bleeding have pre-
viously been investigated and reported [6, 16]. Takizawa
et al. reported that post-ESD coagulation in the resection
area could prevent post-ESD bleeding [6]. The procedure
suggested was the procedure we used, coagulation of visible
vessels in the resection area using hemostatic forceps when
ESD was completed to prevent delayed bleeding. Uedo et al.
reportedthatanendoscopicDopplerultrasoundhaspossible
beneﬁts for prevention of post-ESD bleeding [16]. However,
despite these measures, post-ESD bleeding continues to
occur regularly.
Commonly, a second-look endoscopy is routinely per-
formedthenextdayorafewdaysafterESDbeforebeginning
meals to prevent post-ESD bleeding. However, one study re-
ported that a second-look endoscopy after ESD may contri-
bute little to prevention of post-ESD bleeding [7]. If the freq-
uencyofpost-ESDbleedingwasdecreasedbyimprovedmea-
sures to prevent post-ESD bleeding in the future, a second-
look endoscopy may become unnecessary.
Furthermore, prospective randomized controlled trials
have identiﬁed that the use of PPIs results in signiﬁcantly
lower bleeding rates after ESD than the use of H2-receptor
antagonists[17,18].WealsoadministeredaPPI,20mgome-
prazole, intravenously from the day of ESD to the day before
beginning meals.
Thepresentstudysuggeststhattreatmentofbloodvessels
on a post-ESD lesion, especially for ulcers, middle or lower
regions, or with lesser curves, would contribute to a reduc-
tion in the frequency of post-ESD bleeding. In particular,
detection of arteries on the ulcer is likely important to pre-
vent serious post-ESD bleeding requiring emergent endo-
scopic treatment. The ﬁndings of the present study and fur-
ther investigation of post-ESD bleeding may allow establish-
ment of preventive measures for post-ESD bleeding. More
eﬀective preventive measures may contribute to reducing
the number of days of hospital treatment and the need for
follow-up endoscopy.
The limitations of the present study include its single-
center retrospective study design and small sample size.
Moreover, our data include various uncertain factors, such
as operators, instruments, subjects, and periods.
In conclusion, we found that the presence of ulcers is a
statistically signiﬁcant predictor of post-ESD bleeding, and
that middle or lower regions and post-ESD ulcers with an
extended lesser curve are also considered risk factors.
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